Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers

Annals of Surgery

Volumn 248, Issue 2, 2008, Pages 243-251

  Lim, Seok Byung ^a,b   Choi, Hyo Seong ^a   Jeong, Seung Yong ^a   Kim, Dae Yong ^a   Jung, Kyung Hae ^a,b   Hong, Yong Sang ^a   Chang, Hee Jin ^a   Park, Jae Gahb ^a,c  

^a National Cancer Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ANASTOMOSIS DEHISCENCE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OPERATION DURATION; PREOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RECTUM CANCER; RECTUM RESECTION; RECTUM SURGERY; RECURRENT DISEASE; SURGICAL WOUND; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; AGED; CANCER INVASION; CANCER STAGING; COLON RESECTION; COMPARATIVE STUDY; FOLLOW UP; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROBABILITY; RECTUM TUMOR; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TIME;

ADENOCARCINOMA; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREOPERATIVE CARE; PROBABILITY; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 49849103393     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31817fc2a0     Document Type: Article

References (46)

1. Heald RJ. Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br J Surg. 1995;82:1297-1299.
2. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341:457-460.
3. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
4. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997;336:980-987.
5. Folkesson J, Birgisson H, Pahlman L, et al. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23:5644-5650.
6. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet. 2001;358:1291-1304.
7. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
8. Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg. 2002;236:75-81.
9. Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688-8696.
10. Kim DW, Lim SB, Kim DY, et al. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. Eur JSurg Oncol. 2006;32:162-167.
11. Madoff RD. Chemoradiotherapy for rectal cancer-hen, why, and how? N Engl J Med. 2004;351:1790-1792.
12. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. Clin Oncol. 2001;19:1976 -1984.
13. Delaini GG, ed. Rectal Cancer. New Frontiers in Diagnosis, Treatment, and Rehabilitation. Italy: Springer-Verlag; 2005.
14. Moore HG, Gittleman AE, Minsky BD, et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum. 004;47:279 -286.
15. Kim YH, Kim DY, Kim TH, et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J adiat ncol Biol Phys. 2005;62:761-768.
16. Kim DY, Jung KH, Kim TH, et al. Comparison of 5-fluorouracil/ leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2007;67: 78 -384.
17. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12:19-23.
18. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
19. Gordon PH, Nivatvongs S. Principles and Practice of Surgery for the Colon, Rectum, and Anus. 2nd ed. St. Louis, MO: Quality Medical ublishing, Inc; 1999.
20. Phillips RK, Clark S. Frontiers in Colorectal Surgery. 1st ed. Shrewsbury, UK: TFM publishing Ltd; 2005.
21. Rau B, Sturm I, Lage H, et al. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. J Clin Oncol. 2003;21:3391-3401.
22. Ghadimi BM, Grade M, Difilippantonio MJ, et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol. 2005;23:1826-1838.
23. Watanabe T, Komuro Y, Kiyomatsu T, et al. Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res. 2006;66: 3370-3374.
24. Kim IJ, Lim SB, Kang HC, et al. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in advanced rectal cancer patients. Dis Colon Rectum. 2007;50:1342-1353.
25. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol. 1999;17:2396.
26. Glehen O, Chapet O, Adham M, et al. Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg. 2003;90:996-998.
27. Horn A, Morild I, Dahl O. Tumour shrinkage and down staging after preoperative radiation of rectal adenocarcinomas. Radiother Oncol. 990;18:19-28.
28. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal ancer Working Party. Lancet. 1996;348:1610-1614.
29. Berger C, de Muret A, Garaud P, et al. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int JRadiat Oncol Biol hys. 1997;37:619-627.
30. Kaminsky-Forrett MC, Conroy T, Luporsi E, et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys. 1998;42:935- 941.
31. Pucciarelli S, Toppan P, Friso ML, et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon ectum. 2004;47:1798 -1807.
32. Stein DE, Mahmoud NN, Anne PR, et al. Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum. 003;46:448 -453.
33. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357:497-504.
34. Bissett IP, Fernando CC, Hough DM, et al. Identification of the fascia propria by magnetic resonance imaging and its relevance to preoperative assessment of rectal cancer. Dis Colon Rectum. 2001;44:259 -265.
35. Allen SD, Padhani AR, Dzik-Jurasz AS, et al. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol. 2007;188:442-451.
36. Tran CL, Udani S, Holt A, et al. Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer. Am J Surg. 2006;192:873-877.
37. Lim SB, Heo SC, Lee MR, et al. Changes in outcome with sphincter preserving surgery for rectal cancer in Korea, 1991-2000. Eur J Surg Oncol. 2005;31:242-249.
38. Onaitis MW, Noone RB, Hartwig M, et al. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg. 2001;233:778 -785.
39. Glynne-Jones R, Sebag-Montefiore D. Chemoradiation schedules-what radiotherapy? Eur J Cancer. 2002;38:258 -269.
40. Jung KH, Kim DY, Ahn JB, et al. Phase II study of preoperative concurrent chemoradiotherapy (CRT) with capecitabine (C) plus irino- tecan (I) in locally advanced rectal cancer. 2006 Gastrointestinal Cancers Symposium. ASCO abstract 351.
41. Klautke G, Kiichenmeister U, Foitzik T, et al. Concurrent chemoradia- tion with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br JCancer. 2006;94: 976-981.
42. Willeke F, Horisberger K, Kraus-Tiefenbacher U, et al. A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer. Br J Cancer. 2007;96:912-917.
43. VeenhofAA, Kropman RH, Engel AF, et al. Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery. Int JColorectal Dis. 2007;22:507-513.
44. Supiot S, Bennouna J, Rio E, et al. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. ColorectalDis. 2006;8:430-435.
45. Scholefield JH, Abcarian H, Grothey A, et al. Challenges in Colorectal Cancer. 2nd ed. Boston, MA: Blackwell Publishing, Inc.; 2006.
46. Withers HR, Haustermans K. Where next with preoperative radiation therapy for rectal cancer? Int J Radiat Oncol Biol Phys. 2004;58: 597-602.